Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Roya Kelishadi, MD"'
Autor:
Perry Hystad, PhD, Andrew Larkin, PhD, Sumathy Rangarajan, MSc, Khalid F AlHabib, MBBS, Álvaro Avezum, ProfPhD, Kevser Burcu Tumerdem Calik, MD, Jephat Chifamba, DPhil, Antonio Dans, ProfMD, Rafael Diaz, MD, Johan L du Plessis, PhD, Rajeev Gupta, ProfPhD, Romaina Iqbal, PhD, Rasha Khatib, PhD, Roya Kelishadi, MD, Fernando Lanas, ProfMD, Zhiguang Liu, MPH, Patricio Lopez-Jaramillo, ProfPhD, Sanjeev Nair, MD, Paul Poirier, ProfPhD, Omar Rahman, ProfDSc, Annika Rosengren, ProfMD, Hany Swidan, FRCGP, Lap Ah Tse, PhD, Li Wei, ProfPhD, Andreas Wielgosz, ProfPhD, Karen Yeates, MD, Khalid Yusoff, MBBS, Tomasz Zatoński, PhD, Rick Burnett, PhD, Salim Yusuf, ProfPhD, Michael Brauer, ProfScD
Publikováno v:
The Lancet Planetary Health, Vol 4, Iss 6, Pp e235-e245 (2020)
Summary: Background: Most studies of long-term exposure to outdoor fine particulate matter (PM2·5) and cardiovascular disease are from high-income countries with relatively low PM2·5 concentrations. It is unclear whether risks are similar in low-in
Externí odkaz:
https://doaj.org/article/914381289b814a87808877dc61fce1cd
Autor:
Adrianna Murphy, PhD, Benjamin Palafox, MSc, Owen O'Donnell, ProfPhD, David Stuckler, ProfPhD, Pablo Perel, PhD, Khalid F AlHabib, ProfMBBS, Alvaro Avezum, ProfPhD, Xiulin Bai, BSc, Jephat Chifamba, ProfDPhil, Clara K Chow, ProfPhD, Daniel J Corsi, PhD, Gilles R Dagenais, MD, Antonio L Dans, MD, Rafael Diaz, MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, Roya Kelishadi, MD, Rasha Khatib, PhD, Fernando Lanas, PhD, Scott A Lear, ProfPhD, Wei Li, ProfPhD, Jia Liu, MSc, Patricio Lopez-Jaramillo, ProfPhD, Viswanathan Mohan, ProfMD, Nahed Monsef, PhD, Prem K Mony, MD, Thandi Puoane, ProfDrPH, Sumathy Rangarajan, MSc, Annika Rosengren, ProfMD, Aletta E Schutte, ProfPhD, Mariz Sintaha, MSc, Koon K Teo, ProfPhD, Andreas Wielgosz, ProfMD, Karen Yeates, MD, Lu Yin, PhD, Khalid Yusoff, ProfMBBS, Katarzyna Zatońska, PhD, Salim Yusuf, ProfPhD, Martin McKee, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 6, Iss 3, Pp e292-e301 (2018)
Summary: Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, choleste
Externí odkaz:
https://doaj.org/article/d48fe3873f824d4ca3b3e34e4f9ab7f6
Autor:
Djalalinia S; Shirin Djalalinia, MSc PhD Candidate, Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran, and Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran, and Development of Research & Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran., Qorbani M; Dr. Mostafa Qorbani, PhD, School of Medicine, Community Medicine Department Alborz University of Medical Sciences, Karaj, Iran, and Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Peykari N; Niloofar Peykari, MSc PhD Candidate, Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran, and Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran, and Development of Research & Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran., Kelishadi R; Prof. Roya Kelishadi, MD, Child Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Publikováno v:
Pakistan journal of medical sciences [Pak J Med Sci] 2015 Jan-Feb; Vol. 31 (1), pp. 239-42.